Discover
NSRX
Nasus Pharma Ltd.
3.51
100 x 3.33
100 x 3.65
bid
ask
-
0.12
3.31%
100 @ 06:39 PM
3.65 +0.14 (3.99%)
| Ytd | -61.64% | |
| 1y | -54.71% |
3.48
day range
3.64
2.01
52 week range
9.15
| Open | 3.63 | Prev Close | 3.63 | Low | 3.48 | High | 3.64 | Mkt Cap | 41.12M |
| Vol | 16.92K | Avg Vol | 16.02K | EPS | -1.20 | P/E | N/A | Forward P/E | N/A |
| Beta | 4.18 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 3.63 | 200-d Avg | 3.98 | 1yr Est | 0.00 |
| Income Statement | |||
| Weighted Average Shares | 11.07M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.90M | ||
| Cash and Equivalents (USD) | 7.90M | ||
| Investments | 4.00M | ||
| Investments Current | 4.00M | ||
| Current Assets | 12.31M | ||
| Property, Plant & Equipment Net | 138.00K | ||
| Total Assets | 12.45M | ||
| Debt Current | 54.00K | ||
| Total Debt | 103.00K | ||
| Current Liabilities | 1.40M | ||
| Debt Non-Current | 49.00K | ||
| Total Liabilities | 1.45M | ||
| Accumulated Retained Earnings (Deficit) | -24.46M | ||
| Shareholders Equity | 11.00M | ||
| Shareholders Equity (USD) | 11.00M | ||
| Assets Non-Current | 138.00K | ||
| Total Debt (USD) | 103.00K | ||
| Liabilities Non-Current | 49.00K | ||
| Trade and Non-Trade Payables | 347.00K | ||